These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 16084225)
1. Evaluation of disease severity in familial Mediterranean fever. Mor A; Shinar Y; Zaks N; Langevitz P; Chetrit A; Shtrasburg S; Rabinovitz E; Livneh A Semin Arthritis Rheum; 2005 Aug; 35(1):57-64. PubMed ID: 16084225 [TBL] [Abstract][Full Text] [Related]
2. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. Lidar M; Yaqubov M; Zaks N; Ben-Horin S; Langevitz P; Livneh A J Rheumatol; 2006 Jun; 33(6):1089-92. PubMed ID: 16755655 [TBL] [Abstract][Full Text] [Related]
3. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. Ozel AM; Demirturk L; Aydogdu A; Gultepe M; Yazgan Y; Imirzalioglu N; Gurbuz AK; Narin Y Int J Clin Pract; 2008 May; 62(5):754-61. PubMed ID: 17343670 [TBL] [Abstract][Full Text] [Related]
4. Familial Mediterranean fever in northwest of Iran (Ardabil): the first global report from Iran. Salehzadeh F; Emami D; Zolfegari AA; Yazdanbod A; Habibzadeh S; Bashardost B; Barak M; Feizi I; Azimi H; Jastan M; Khalafi J Turk J Pediatr; 2008; 50(1):40-4. PubMed ID: 18365590 [TBL] [Abstract][Full Text] [Related]
5. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Yalçinkaya F; Ozen S; Ozçakar ZB; Aktay N; Cakar N; Düzova A; Kasapçopur O; Elhan AH; Doganay B; Ekim M; Kara N; Uncu N; Bakkaloglu A Rheumatology (Oxford); 2009 Apr; 48(4):395-8. PubMed ID: 19193696 [TBL] [Abstract][Full Text] [Related]
6. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever. Sahin S; Sahin GM; Ergin H; Kantarci G Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446 [TBL] [Abstract][Full Text] [Related]
7. Relation between microalbuminuria and gene mutations in familial Mediterranean fever. Ergüven M; Emeksiz C; Deveci M; Ozlü SG Turk J Pediatr; 2008; 50(4):326-30. PubMed ID: 19014044 [TBL] [Abstract][Full Text] [Related]
8. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever. Kisacik B; Akdogan A; Yilmaz G; Karadag O; Yilmaz FM; Koklu S; Yuksel O; Ertenli AI; Kiraz S Eur J Intern Med; 2009 Jan; 20(1):44-7. PubMed ID: 19237091 [TBL] [Abstract][Full Text] [Related]
9. FMF50: a score for assessing outcome in familial Mediterranean fever. Ozen S; Demirkaya E; Duzova A; Erdogan O; Erken E; Gul A; Kasapcopur O; Kasifoglu T; Kisacik B; Ozdogan H; Tunca M; Acikel C; Ann Rheum Dis; 2014 May; 73(5):897-901. PubMed ID: 24570027 [TBL] [Abstract][Full Text] [Related]
10. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Aletaha D; Ward MM; Machold KP; Nell VP; Stamm T; Smolen JS Arthritis Rheum; 2005 Sep; 52(9):2625-36. PubMed ID: 16142705 [TBL] [Abstract][Full Text] [Related]
11. Search for disease-specific cardiovascular reactivity patterns: developing the methodology. Naschitz JE; Rozenbaum M; Fields M; Isseroff H; Enis S; Babich JP; Peck S; Peck ER; Gaitini L; Naschitz S; Sabo E; Rosner I Clin Sci (Lond); 2005 Jan; 108(1):37-46. PubMed ID: 15330754 [TBL] [Abstract][Full Text] [Related]
12. Sweet's syndrome in familial Mediterranean fever: possible continuum of the neutrophilic reaction as a new cutaneous feature of FMF. Oskay T; Anadolu R J Cutan Pathol; 2009 Aug; 36(8):901-5. PubMed ID: 19586502 [TBL] [Abstract][Full Text] [Related]
13. Criteria for the diagnosis of familial Mediterranean fever. Livneh A; Langevitz P; Zemer D; Zaks N; Kees S; Lidar T; Migdal A; Padeh S; Pras M Arthritis Rheum; 1997 Oct; 40(10):1879-85. PubMed ID: 9336425 [TBL] [Abstract][Full Text] [Related]
14. The anemia of familial Mediterranean fever disease. Celkan T; Celik M; Kasapçopur O; Ozkan A; Apak H; Ocak S; Arisoy N; Yildiz I Pediatr Hematol Oncol; 2005 Dec; 22(8):657-65. PubMed ID: 16251171 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever. Tweezer-Zaks N; Rabinovich E; Lidar M; Livneh A J Rheumatol; 2008 Jul; 35(7):1362-5. PubMed ID: 18528960 [TBL] [Abstract][Full Text] [Related]
17. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Demirkaya E; Acikel C; Hashkes P; Gattorno M; Gul A; Ozdogan H; Turker T; Karadag O; Livneh A; Ben-Chetrit E; Ozen S; Ann Rheum Dis; 2016 Jun; 75(6):1051-6. PubMed ID: 26823530 [TBL] [Abstract][Full Text] [Related]
18. Relationship of Tel Hashomer criteria and Mediterranean fever gene mutations in a cohort of Turkish familial Mediterranean fever patients. Samli H; Dogru O; Bukulmez A; Yuksel E; Ovali F; Solak M Saudi Med J; 2006 Dec; 27(12):1822-6. PubMed ID: 17143356 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis. Karahan ZC; Ozturk A; Akar E; Akar N J Nephrol; 2005; 18(5):582-4. PubMed ID: 16299685 [TBL] [Abstract][Full Text] [Related]